| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68788-9815-6 | 68788-9815 | HUMAN PRESCRIPTION DRUG | Terazosin hydrochloride | Terazosin hydrochloride | CAPSULE | ORAL | 20120405 | N/A | ANDA | ANDA075317 | Preferred Pharmaceuticals, Inc | TERAZOSIN HYDROCHLORIDE | 5 mg/1 | 60 CAPSULE in 1 BOTTLE (68788-9815-6) |
| 68788-9815-9 | 68788-9815 | HUMAN PRESCRIPTION DRUG | Terazosin hydrochloride | Terazosin hydrochloride | CAPSULE | ORAL | 20120405 | N/A | ANDA | ANDA075317 | Preferred Pharmaceuticals, Inc | TERAZOSIN HYDROCHLORIDE | 5 mg/1 | 90 CAPSULE in 1 BOTTLE (68788-9815-9) |
| 42291-820-10 | 42291-820 | HUMAN PRESCRIPTION DRUG | Terazosin | Terazosin Hydrochloride | CAPSULE | ORAL | 20200330 | N/A | ANDA | ANDA075317 | AvKARE | TERAZOSIN HYDROCHLORIDE | 1 mg/1 | 1000 CAPSULE in 1 BOTTLE (42291-820-10) |